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Case Report
Thyroidectomy for medullary carcinoma in MEN 2A:
Positive genetic screening as the sole indicator for surgery
D McNally, W J Campbell, J M Sloan, P J Morrison, C F J Russell
The multiple endocrine neoplasia type 2A
syndrome (MEN 2A), comprising medullary
thyroid carcinoma (MTC), phaeochromocytoma
and primary hyperparathyroidism, is inherited in
autosomal dominant fashion on chromosome 10.
The specific genetic abnormality was initially
localised to a site close to the centromere of
chromosome 101,2 and, more recently, has been
identified as a mutation (most commonly exons
10 and 11) in the RET proto-oncogene.3 As the
invariable component of MEN 2, medullary
thyroid carcinoma is present in all affected
individuals. Previously, the presence of tumour
within a family membercould only be confirmed
either by the detection ofclinical disease (goitre
or cervical lymphadenopathy) or by the finding
ofelevated levels ofplasma calcitonin measured
basallyorfollowing stimulation withacalcitonin
secretagogue such as pentagastrin or calcium.
The identification of the specific genetic defect
in MEN 2A now permits diagnosis of the
syndrome, following routine blood sampling, in
patients whomayhavenoclinical orbiochemical
stigmata ofdisease. We record the management
of a 10-year-old girl from a known MEN 2A
family,4who underwent thyroidectomy solely on
the basis ofgenetic information. We believe this
tobethefirstreported occasion withintheUnited
Kingdomwhenapatienthasundergoneoperation
in these circumstances.
Case Report
Screening ofthe 10-year-old daughter ofa MEN
2Afamily memberrevealedthepresence ofa634
Cys-TyrmutationwithintheRETgene. Herfather
had previously undergone total thyroidectomy
for medullary carcinoma and bilateral
adrenalectomy for phaeochromocytoma. Basal
plasn-ta calcitonin values at age 5, 6 and 10 years
were normal. Pentagastrin stimulation testing
whicb-oftenresults in significantretrosternal and
abdoitinal discomfort, had not been carried out
in this child. Clinical examination on each of
these occasions had revealed no evidence of
palpable goitre or lymphadenopathy. Urinary
catecholamine levels and serum calcium were
not estimated, as phaeochromocytoma and
hyperparathyroidism, ifpresent in an individual
MEN 2 patient, invariably develop much later.
Following appropriate discussion with parents,
andsolelyonthebasisofthegeneticinformation,
total thyroidectomy was carried out in January
Figure
Small focus of medullary cell carcinoma infiltrating
thyroid tissue. Immunocytochemistry showed tumour
cells staining positively for calcitonin and CEA.
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1995. At operation the thyroid gland was grossly
normal. However, careful histological examin-
ation of the surgical specimen revealed the
presence ofC-cell hyperplasia and several small
foci of frankly invasive medullary carcinoma
(Fig.). Thelargestofthese was0.5 cm. maximum
diameter. Two adjacentlymphnodes which were
submitted contained no tumour. At 24-month
review the patient is clinically free of disease,
with unrecordable plasma calcitonin values.
DISCUSSION
Untilrecently, identificationofaffectedmembers
within MEN 2A kindreds was dependent upon
theappearanceofclinicalorbiochemical-evidence
of MTC after repeated and often prolonged
screening. With the recognition of specific RET
mutations responsible for the syndrome, its
presence can now be confirmed in over 98 per
cent of affected individuals following a routine
blood sample. Equally important, non-affected
family members canbereassured anddischarged
from further screening. Previously, the decision
to advise thyroidectomy has usually been taken
only whentheplasmacalcitoninlevelhasbecome
elevated, thus indicating the presence ofMTC or
its precursor, C-cell hyperplasia. Now, with the
reality of a positive diagnosis made solely on
genetic grounds, there is the potential for even
earliersurgicalintervention,withgreatercertainty
for cure of the thyroid cancer. Following the
pioneering work of Wells and colleagues5 we
advised 'prophylactic' thyroidectomy in our
patient exclusively on the basis of the genetic
information. The histology suggests that the
operation was in fact 'therapeutic' and lends
support to the belief that thyroidectomy at an
even younger age may be appropriate in such
circumstances.
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